Welcome!
SAC Capital
Broker's Calls
SAC Capital initiates coverage on Livingstone Health with 'hold' call
The group was listed on the Singapore Exchange (SGX) via a reverse takeover in 2021.
February 04, 2022
Broker's Calls
SAC Capital downgrades GKE with reduced target price of 12.3 cents
GKE's 1HFY2022 earnings missed expectations
January 26, 2022
Broker's Calls
SAC Capital initiates coverage on Marco Polo Marine with 'buy' call at 3.2 cent price target
The 3.2 cent target is pegged to 8.0x FY2022 EV/EBITDA
January 04, 2022
Broker's Calls
Analysts raise estimates on PropNex after 3QFY21 earnings meet and, or surpass expectations
Shares in PropNex closed flat at $1.78 on Nov 30.
November 30, 2021
Capital markets
Beng Kuang Marine raises $3.35 million via placement at 9 cents per share
A total of 37.2 million new shares have been placed out.
October 18, 2021
Broker's Calls
Roxy-Pacific's privatisation offer catches the eye of SAC Capital
SAC Capital analyst Tracy Lim believes that Roxy-Pacific is emerging from the trough
September 23, 2021
Broker's Calls
PhillipCapital sees 'more positive outlook' on Koufu despite 'neutral' rating; SAC Capital keeps 'buy' on the counter
In the 1HFY2021 ended June, Koufu reported earnings of $9.9 million, nearly four times higher y-o-y.
September 06, 2021
Broker's Calls
SAC Capital initiates 'buy' on OTS Holdings as expansion plans expected to bear fruit
Recently listed OTS Holdings gets a 'buy' from SAC Capital.
September 03, 2021
Broker's Calls
SAC Capital maintains 'hold' on PropNex but ups target price to $2
The higher TP reflects the strong momentum of the property market that’s expected to continue in the near term.
August 27, 2021
Broker's Calls
Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives
SAC Capital is maintaining its “buy” call and target price of 37 cents on pharmaceutical distributor Hyphens Pharma.
August 27, 2021